News Column

Akers Biosciences Breath Device Granted Patent

July 17, 2014

Alice Attwood

LONDON (Alliance News) - Akers Biosciences INC said Thursday that the United States Patent and Trademark Office has granted a patent covering Akers' Breath Ketone detection device.

The Breath Ketone detection device is based upon Akers' proprietary MPC Biosensor Technology which permits the rapid identification of medical conditions through biomarkers in exhaled breath.

Since breath and blood ketone levels are closely correlated, Akers' Breath Ketone "Check" product is designed to offer healthcare professionals and their patients a convenient method to quickly determine if an individual's ketone level is approaching a dangerous threshold requiring medical attention.

The device has further applications in the medical and non-medical weight management areas, said Akers, for example where the measurement of ketone production is used to monitor the burning of body fat. The company is currently marketing a version of the product to weight loss centres.

Shares in Akers Biosciences were Thursday trading marginally higher, up 0.19% at 268.00 pence per share.

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Alliance News

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters